Clinical Trials Sponsored by Aegerion Pharmaceuticals, Inc

Total 4981 results

Aegerion Pharmaceuticals, Inc.

Completed

Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia

Hypercholesterolemia

United States
Aegerion Pharmaceuticals, Inc.

Completed

Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

Hyperlipidemia

United States
Aegerion Pharmaceuticals, Inc.

Recruiting

MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE)

Partial Lipodystrophy | Generalised Lipodystrophy

United States, Germany, Italy
Aegerion Pharmaceuticals, Inc.

Active, not recruiting

Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy

Generalized Lipodystrophy

United States
Aegerion Pharmaceuticals, Inc.

Completed

Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.

Effect of Atorvastatin on the Pharmacokinetics of Lomitapide

United States
Aegerion Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

Familial Hypercholesterolemia - Homozygous

Japan
Aegerion Pharmaceuticals, Inc.

Completed

AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia

Hypercholesterolemia

United States
Aegerion Pharmaceuticals, Inc.

Completed

Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

Healthy

United States
Aegerion Pharmaceuticals, Inc.

Withdrawn

Effects of Lomitapide on Carotid and Aortic Atherosclerosis

Homozygous Familial Hypercholesterolemia
Aegerion Pharmaceuticals, Inc.

Completed

The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia

Hypercholesterolemia

United States
Aegerion Pharmaceuticals, Inc.

Completed

Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects

Intra-subject Variability of Pharmacokinetics

United Kingdom
Aegerion Pharmaceuticals, Inc.

Completed

Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

Healthy

United States
Aegerion Pharmaceuticals, Inc.

Completed

Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia

United States, Canada, Italy, South Africa
Aegerion Pharmaceuticals, Inc.

Withdrawn

Evaluate the Efficacy and Safety of Lomitapide in Pediatric Patients With Homozygous Familial Hypercholesterolemia on Stable Lipid-lowering Therapy

Homozygous Familial Hypercholesterolemia
Aegerion Pharmaceuticals, Inc.

Completed

A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled

Healthy

United Kingdom
Aegerion Pharmaceuticals, Inc.
Richmond Pharmacology Limited

Completed

Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C

Healthy Volunteer

United Kingdom
Promentis Pharmaceuticals, Inc.
Celerion

Completed

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers

Healthy

United States
Madrigal Pharmaceuticals, Inc.
Celerion

Completed

Bioavailability Study of MGL-3196 Tablets Compared to Capsules

Healthy

United States
University College, London
Aegerion Pharmaceuticals, Inc.

Completed

Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry

Percutaneous Coronary Intervention | Familial Hypercholesterolemia | Cardiac Event
Madrigal Pharmaceuticals, Inc.
Celerion

Completed

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

Healthy

United States
Afferent Pharmaceuticals, Inc.
Celerion

Completed

A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)

Healthy Volunteers
Afferent Pharmaceuticals, Inc.
Celerion

Completed

A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations

Healthy

United States
Alexza Pharmaceuticals, Inc.
Celerion

Completed

Staccato® Granisetron Multiple Dose PK

Healthy

United States
Alexza Pharmaceuticals, Inc.
Celerion

Completed

Staccato® Granisetron Single Dose PK

Healthy

United States
Wex Pharmaceuticals Inc.
Celerion

Completed

A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

TQT Study

United States
Madrigal Pharmaceuticals, Inc.
Celerion

Completed

Drug Interaction Study of MGL-3196 With Atorvastatin

Healthy

United States
Algernon Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Otsuka Pharmaceutical Factory, Inc.
Celerion

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects

Obesity

United States
Concert Pharmaceuticals
Celerion

Completed

Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects

Healthy Volunteers

United States
Aegerion Pharmaceuticals, Inc.
FDA Office of Orphan Products Development

Completed

A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

Homozygous Familial Hypercholesterolemia

United States, Canada, Italy, South Africa
Alexion Pharmaceuticals
Celerion

Completed

A Study of the Cardiac Effects of ALXN2050 in Healthy Adults

Healthy

United States
Alexion Pharmaceuticals
Celerion

Completed

Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants

Healthy

United States
Xoc Pharmaceuticals
Celerion

Active, not recruiting

Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects

Parkinson's Disease

United States
Alexion Pharmaceuticals
Celerion

Completed

Study of the Metabolism of Danicopan in Healthy Adults

Healthy

United States
Concert Pharmaceuticals
Celerion

Completed

Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers

Healthy Volunteers

United States
Aegerion Pharmaceuticals, Inc.
University of Pennsylvania; Doris Duke Charitable Foundation

Completed

Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor

Homozygous Familial Hypercholesterolemia

United States
Algernon Pharmaceuticals
Novotech (Australia)

Completed

Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease

COVID

Philippines, Australia, United States, Romania
Savara Inc.
Celerion

Completed

Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

Bronchiectasis | Cystic Fibrosis | Acute Respiratory Distress Syndrome | Pulmonary Alveolar Proteinosis

United Kingdom
Pulmatrix Inc.
Celerion

Completed

A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

Cystic Fibrosis

United Kingdom
Promentis Pharmaceuticals, Inc.
Baylor College of Medicine; Celerion

Completed

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

Impulse Control Disorders

United States
Aronora, Inc.
Celerion

Completed

Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Thrombosis | End Stage Renal Disease

United States
Achaogen, Inc.
Celerion

Completed

A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin

Healthy Volunteers

United States
Celtaxsys, Inc.
Celerion

Completed

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

Cystic Fibrosis

United Kingdom
Aperion Biologics, Inc.

Unknown

Safety and Efficacy Study of the Z-Lig Medical Device Compared to Allograft (Z-Lig)

Ruptured Anterior Cruciate Ligaments

Italy, Belgium, Denmark, Netherlands, South Africa, Spain
Juul Labs, Inc.
Celerion

Completed

Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers (Diamond)

Tobacco Use | Smoking, Tobacco | Nicotine Dependence, Other Tobacco Product

United States
Galera Therapeutics, Inc.
Celerion

Completed

A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects

Healthy | Healthy Volunteers

United States
Clarus Therapeutics, Inc.
Celerion

Completed

The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate

Hypogonadism

United States
Neuropore Therapies Inc.
Celerion

Completed

A Study to Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects

Healthy Volunteers

United States
Repros Therapeutics Inc.
Celerion

Completed

An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration

Secondary Hypogonadism

United States
Jazz Pharmaceuticals
Dana-Farber Cancer Institute; Celerion; LifeWatch Services, Inc.

Completed

Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers

Healthy

United States

Clinical Trials Sponsored by Aegerion Pharmaceuticals, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations